{"id":5,"date":"2018-09-12T10:50:17","date_gmt":"2018-09-12T01:50:17","guid":{"rendered":"https:\/\/sar.pharm.or.jp\/?page_id=5"},"modified":"2018-10-25T10:10:55","modified_gmt":"2018-10-25T01:10:55","slug":"about","status":"publish","type":"page","link":"https:\/\/sar.pharm.or.jp\/en\/about\/","title":{"rendered":"About us"},"content":{"rendered":"<p><\/p>\n<p><a name=\"goal\"><\/a><\/p>\n<h2>The Aim of the Division of Structure-Activity Studies<\/h2>\n<p>The aim of the Division is primarily to promote and encourage the basic and applied research in the field of structure-activity-relationship and related studies. <br \/>\nThe Division provides a venue to present research activities, to exchange knowledge and information, to enable stimulated discussions, and to facilitate collaboration for scientists active in structure-activity- relationship, structure-toxicity relationship, molecular\/drug design, and related fields. <br \/>\nThus, the Division hopefully expects to ensure the scientific background in developments of novel pharmaceutical and agrochemical agents as well as logical models\/concepts for environmental remediation through its activity.<\/p>\n<p>In order to achieve the aim, the Division: organizes the Symposium for Structure-Activity Relationships annually, organizes the Structure-Activity Forum annually, and issues its own electronic news letters, SAR News (in Japanese), connected with the activity of the Division.<\/p>\n<p>The divisional activity covers such topics as shown below:<\/p>\n<ol>\n<li>Methodologies for analyses of structure-activity\/toxicity relationships of pharmaceutical and agrochemical agents and procedures for drug-design,<\/li>\n<li>Molecular mechanism of interaction between drug and biopolymer,<\/li>\n<li>Structure and function of biopolymers relating to structure-based and receptor-based drug design,<\/li>\n<li>Structure-activity and structure-property relationships of environmental pollutants including endocrine-active substances, andStructure and characteristics of drugs such as absorption, distribution, metabolism, excretion, and toxicology,<\/li>\n<li>Database utilizing and information processing technologies relating to bioactive compounds such as pharmaceutical and agrochemical agents.\n<\/li>\n<\/ol>\n<p><a name=\"about\"><\/a><\/p>\n<h2>A Brief History of the Symposium of Structure-Activity Relationships<\/h2>\n<p>As mentioned avobe, the principal activities of the Division are to organize the Symposium of Structure-Activity Relationships and the Structure-Activity Forum [an instructive meeting with lectures and discussions relating to topics such as structure-activity relationships, drug design, and related areas], annually. <br \/>\nIn fact, these activities were initiated by the Association of Structure-Activity-Relationship (SAR) Studies, a volunteer group of pharmaceutical and agrochemical scientists. <br \/>\nThe origin of the Association can be traced back to 1975, when the 1st Symposium was held in Kyoto, Japan.<\/p>\n<p> In early 1960&#8217;s, various concepts and procedures were newly disclosed and proposed to analyze structure-activity relationships of bioactive compounds mostly in the United States. <br \/>\nThese procedures are based on quantitative mathematical models backed up by statistics and\/or physical organic chemistry. <br \/>\nPerhaps supported by the progress of computer technology as well as medicinal bioorganic chemistry, the speed in the development of these quantitative procedures was rather quick during the late 1960&#8217;s and quite a few symposia began to be organized internationally in the United States and Europe in the early 1970&#8217;s. <br \/>\nUnder these circumstances, the Association of SAR Studies was founded in 1975 by Professor Toshio Fujita of Kyoto University to offer a forum, where mutual communications and exchange of information about updated international movements in related fields could be enabled, to domestic scientists. <br \/>\nThus, the Association organized the 1st Symposium in the same year and continued to be the organizing body of the Symposium annually since then. <br \/>\nThe Association also opened the Forum several times during the same period. <br \/>\nBesides these activities, the Association edited two instructive books (in Japanese) for the analyses of quantitative structure-activity relationships as supplementary volumes of &#8220;Kagaku no Ryoiki&#8221; (Journal of Japan Chemistry) in 1979 and 1982 and published them from Nankodo.<\/p>\n<p>In 1993, the symposium was incorporated as one of the activities of the Division of Medicinal Chemistry of the Pharmaceutical Society of Japan. <br \/>\nWith above activities of the Association and thanks to great efforts of Professor Hiroshi Terada of the University of Tokushima (Chair of the Association 1994 ~ 2002, President of the Pharmaceutical Society of Japan 1999 ~ 2000), the Division of Structure-Activity Studies was established in the Society in 2002 (Chair: Professor Hideaki Fujiwara of Osaka University), and the Symposium and Forum have been &#8220;upgraded&#8221; to the divisional activities directly supported by the Pharmaceutical Society.<br \/>\nThe early history of the Symposium as well as the Association is described more in detail in the Association news letter (now the division news letter), SAR News No. 1 (2001).<\/p>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<h2>About us<\/h2>\n<ul>\n<li><a href=\"#goal\">The Aim of the Division of Structure-Activity Studies<\/a><\/li>\n<li><a href=\"#about\">A Brief History of the Symposium of Structure-Activity Relationships<\/a><\/li>\n<\/ul>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-5","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/sar.pharm.or.jp\/en\/wp-json\/wp\/v2\/pages\/5","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sar.pharm.or.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sar.pharm.or.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sar.pharm.or.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sar.pharm.or.jp\/en\/wp-json\/wp\/v2\/comments?post=5"}],"version-history":[{"count":17,"href":"https:\/\/sar.pharm.or.jp\/en\/wp-json\/wp\/v2\/pages\/5\/revisions"}],"predecessor-version":[{"id":780,"href":"https:\/\/sar.pharm.or.jp\/en\/wp-json\/wp\/v2\/pages\/5\/revisions\/780"}],"wp:attachment":[{"href":"https:\/\/sar.pharm.or.jp\/en\/wp-json\/wp\/v2\/media?parent=5"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}